- Home
- STX vs TMO Comparison
STX vs TMO Comparison
Compare STX & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STX | TMO |
|---|---|---|
| Founded | 1978 | 1956 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.2B | 164.3B |
| IPO Year | 2002 | 1996 |
Fundamental Metrics
Financial Performance| Metric | STX | TMO |
|---|---|---|
| Price | $1,038.03 | $467.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 18 |
| Target Price | $604.14 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 3.4M | 2.2M |
| Earning Date | 04-28-2026 | 04-23-2026 |
| Dividend Yield | ★ 0.46% | 0.40% |
| EPS Growth | ★ 328.48 | 7.32 |
| EPS | ★ 8.29 | 4.43 |
| Revenue | $7,384,000,000.00 | ★ $20,918,000,000.00 |
| Revenue This Year | $27.73 | $6.55 |
| Revenue Next Year | $25.06 | $5.11 |
| P/E Ratio | $131.97 | ★ $104.74 |
| Revenue Growth | N/A | ★ 14.47 |
| 52 Week Low | $138.31 | $398.08 |
| 52 Week High | $1,145.00 | $643.99 |
Technical Indicators
Market Signals| Indicator | STX | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 65.58 | 48.17 |
| Support Level | $231.23 | $456.87 |
| Resistance Level | N/A | $494.30 |
| Average True Range (ATR) | 63.34 | 11.94 |
| MACD | 9.58 | -1.13 |
| Stochastic Oscillator | 67.92 | 27.86 |
Price Performance
Historical ComparisonAbout STX Seagate Technology Holdings PLC (Ireland)
Seagate Technology is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).